Close
Patheon

News Releases

  • 02 Mar 2017
    DURHAM, N.C.--(BUSINESS WIRE)--Patheon N.V. (NYSE: PTHN), a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, announced that the company was selected as the winner of the “Supply Chain Resiliency Partner of the Year” award by the Global Supply Chain Resiliency Council. The award was presented at RESILIENCE 2017, the Annual Global Supply Chain Resiliency Council Conference and Awards Gala onmore...
  • 01 Feb 2017

    Company Gains Additional API Capacity and Major Supply Agreement with Roche

    DURHAM, N.C.--(BUSINESS WIRE)--Patheon N.V (NYSE: PTHN), a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, announced that it has completed the acquisition of a state-of-the-art manufacturing facility in Florence, South Carolina from Roche Holdings, Inc. Patheon has begun integrating the site into the Patheon network. The site adds a 300,000 square-foot facility with manufacturingmore...
  • 28 Nov 2016

    Company Gains Additional API Capacity and Major Supply Agreement with Roche

    DURHAM, N.C.--(BUSINESS WIRE)--Patheon N.V. ("Patheon" or the "company") (NYSE:PTHN), a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, announced that it has signed a definitive agreement to acquire a state-of-the-art active pharmaceutical ingredients (API) manufacturing facility in Florence, South Carolina, from Roche Holdings, Inc., an indirect, wholly owned subsidiary of Roche Holding Ltdmore...